What are the factors in risk prediction models for rehospitalisation for adults with chronic heart failure?

Australian Critical Care

Volumn 25, Issue 1, 2012, Pages 31-40

  Betihavas, Vasiliki ^a,b   Davidson, Patricia M ^a,c   Newton, Phillip J ^a   Frost, Steven A ^b   Macdonald, Peter S ^d   Stewart, Simon ^e  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c St Vincent's and Mater Health   (Australia)

^d VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Heart failure; Patient readmission; Primary prevention; Risk factors

Indexed keywords

EID: 84857119337     PISSN: 10367314     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aucc.2011.07.004     Document Type: Article

References (48)

1. Adams J.K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209-216.
2. Rodriguez-Artalejo F., Guallar-Castillon P., Banegas Banegas J.R., del Rey Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J 1997, 18:1771-1779.
3. Reitsma J.B., Mosterd A., de Craen A.J., Koster R.W., van Capelle F.J., Grobbee D.E., et al. Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. Heart 1996, 76:388-392.
4. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J.V., Ponikowski P., Poole-Wilson P.A., et al. ESC Guidelines for the Diagnosis And Treatment of Acute And Chronic Heart Failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2422.
5. Australian Institute of Health Welfare Australia's Health 2008 2008, Australian Institute of Health and Welfare, Canberra, [Cat. no. AUS 99].
6. Sochalski J., Jaarsma T., Krumholz H.M., Laramee A., McMurray J.J.V., Naylor M.D., et al. What works in chronic care management: the case of heart failure. Health Aff 2009, 28:179-189.
7. Begg S., Vos T., Barker B., Stevenson C., Stanley L., Lopez A.D. The burden of disease and injury in Australia (2003) 2007, Australian Institute of Health and Welfare (AIHW), Canberra.
8. Ross P.L., Scardino P.T., Kattan M.W. A catalog of prostate cancer nomograms. J Urol 2001, 165:1562-1568.
9. Moons K.G.M., Donders A.R.T., Steyerberg E.W., Harrell F.E. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. J Clin Epidemiol 2004, 57:1262-1270.
10. Harrell F.E., Lee K.L., Mark D. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
11. Steyerberg E.W. Clinical prediction models: a practical approach to development, validation, and updating 2009, Springer, New York.
12. Cui J. Overview of risk prediction models in cardiovascular disease research. Ann Epidemiol 2009, 19:711-717.
13. Ross J.S., Mulvey G.K., Stauffer B., Patlolla V., Bernheim S.M., Keenan P.S., et al. Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med 2008, 168:1371-1386.
14. Amarasingham R., Moore B.J., Tabak Y.P., Drazner M.H., Clark C.A., Zhang S., et al. An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Med Care 2010, 48:981-988.
15. Chin M.H., Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol 1997, 79:1640-1644.
16. Philbin E.F., DiSalvo T.G. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol 1999, 33:1560-1566.
17. Krumholz H.M., Chen Y-T., Wang Y., Vaccarino V., Radford M.J., Horwitz R.I. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000, 139:72-77.
18. Felker G.M., Leimberger J.D., Califf R.M., Cuffe M.S., Massie B.M., Adams K.F., et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail 2004, 10:460-466.
19. Yamokoski L.M., Hasselblad V., Moser D.K., Binanay C., Conway G.A., Glotzer J.M., et al. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail 2007, 13:8-13.
20. Westert G.P., Lagoe R.J., Keskimäki I., Leyland A., Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002, 61:269-278.
21. Filippatos G., Rossi J., Lloyd-Jones D.M., Stough W.G., Ouyang J., Shin D.D., et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail 2007, 13:360-364.
22. Domanski M., Tian X., Haigney M., Pitt B. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail 2006, 12:327-332. [see comment].
23. Wunsch H., Harrison D.A., Rowan K. Health services research in critical care using administrative data. J Crit Care 2005, 20:264-269.
24. Himelhoch S.M.D.M.P.H., Weller W.E.P., Wu A.W.M.D.M.P.H., Anderson G.F.P., Cooper L.A.M.D.M.P.H. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care 2004, 42:512-521.
25. Chung M.L., Lennie T.A., Riegel B., Wu J-R., Dekker R.L., Moser D.K. Marital status as an independent predictor of event-free survival of patients with heart failure. Am J Crit Care 2009, 18:562-570.
26. Cleland J.G.F., Swedberg K., Follath F., Komajda M., Cohen-Solal A., Aguilar J.C., et al. The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003, 24:442-463.
27. Bueno H., Ross J.S., Wang Y., Chen J., Vidan M.T., Normand S-LT, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010, 303:2141-2147.
28. Kimmelstiel C.M.D., Levine D.M.D., Perry K.R.N., Patel A.R.M.D., Sadaniantz A.M.D., Gorham N.R.N., et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation 2004, 110:1450-1455.
29. McAlister F.A., Lawson F.M.E., Teo K.K., Armstrong P.W. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001, 110:378-384.
30. Herlitz J., Wikstrand J., Denny M., Fenster P., Heywood T., Masszi G., et al. Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension. J Card Fail 2002, 8:8-14.
31. Gullestad L., Wikstrand J., Deedwania P., Hjalmarson Å., Egstrup K., Elkayam U., et al. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol 2005, 45:252-259.
32. Ghali J.K., Pina I.L., Gottlieb S.S., Deedwania P.C., Wikstrand J.C., Group M-H.S. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002, 105:1585-1591. [see comment].
33. Butler J., Young J.B., Abraham W.T., Bourge R.C., Adams K.F., Clare R., et al. Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 2006, 47:2462-2469.
34. Flather M.D., Yusuf S., Køber L., Pfeffer M., Hall A., Murray G., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. The Lancet 2000, 355:1575-1581.
35. Naylor M.D., Brooten D.A., Campbell R.L., Maislin G., McCauley K.M., Schwartz J.S. Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J Am Geriatr Soc 2004, 52:675-684. [see comment] [erratum appears in J Am Geriatr Soc 2004;52(July (7)):1228].
36. Jaarsma T. Health care professionals in a heart failure team. Eur J Heart Fail 2005, 7:343-349.
37. Stewart S., Marley J.E., Horowitz J.D. Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. The Lancet 1999, 354:1077-1083.
38. Phillips C.O., Wright S.M., Kern D.E., Singa R.M., Shepperd S., Rubin H.R. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. J Am Med Assoc 2004, 291:1358-1367.
39. Krumholz H.M., Amatruda J., Smith G.L., Mattera J.A., Roumanis S.A., Radford M.J., et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002, 39:83-89.
40. Phillips S.M., Marton R.L., Tofler G. Barriers to diagnosing and managing heart failure in primary care. Med J Aust 2004, 181:78-81.
41. Komajda M., Lapuerta P., Hermans N., Gonzalez-Juanatey J.R., van Veldhuisen D.J., Erdmann E., et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005, 26:1653-1659.
42. Komajda M., Anker S.D., Charlesworth A., Okonko D., Metra M., Di Lenarda A., et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 2006, 27:1440-1446.
43. Gheorghiade M., Rossi J.S., Cotts W., Shin D.D., Hellkamp A.S., Pina I.L., et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med 2007, 167:1998-2005.
44. Braunstein J.B., Anderson G.F., Gerstenblith G., Weller W., Niefeld M., Herbert R., et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003, 42:1226-1233.
45. McKee P., castelli W., McNamara P., Kannel W. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285:1441-1446.
46. World Health Organization Adherence to long-term therapies: evidence for action 2003, World Health Organization, Geneva, Switzerland.
47. Cole J.A., Norman H., Weatherby L.B., Walker A.M. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy 2006, 26:1157-1164.
48. Tabak Y.P., Johannes R.S., Silber J.H. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care 2007, 45:789-805.